{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "", "close" : "", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
marketwire

Kalimantan Gold Plans Private Placement

  • Press Release
  • Source: Kalimantan Gold Corporation Limited
  • On 2:00 am EDT, Friday March 13, 2009

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 13, 2009) - Kalimantan Gold Corporation Limited (TSX VENTURE:KLG - News; AIM:KLG) plans to raise up to $500,000 from a non-brokered private placement financing from the sale of up to 10,000,000 common shares at a price of $0.05 per share. The private placement is subject to compliance with applicable securities laws and to receipt of regulatory approval.

The Company intends to use the proceeds from the private placement to fund its ongoing gold and coal exploration programs in Indonesia, as well as general working capital purposes.

About Kalimantan Gold

Kalimantan Gold Corporation Limited is a junior exploration company listed on both the TSX Venture Exchange in Canada and on AIM. The company is focused on gold, copper and coal prospects in Indonesia and has exploration rights in three areas: the Jelai epithermal gold prospect in East Kalimantan, five coal prospects in Kalimantan and porphyry copper and gold prospects in Central Kalimantan.

RFC Corporate Finance Ltd acts as KLG's Nominated Adviser for the purposes of its AIM listing, contact Stuart Laing, ph: +618 9480 2506 or email: stuartl@rfc.com.au.

The TSX Venture Exchange does not accept responsibility for the adequacy or the accuracy of this release.

Contact:

Rahman Connelly
Kalimantan Gold Corporation Limited
Deputy Chairman and CEO
+61 7 552 32298 or +61 418 116 955
Email: rconnelly@ozemail.com.au
Website: www.kalimantan.com

Sponsored Links

Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.